In vivo changes of guanosine 3',5'-cyclic phosphate in rat cerebellum by dopaminergic mechanisms.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001286:Atropine Derivatives; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology*; D007700:Kinetics; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008297:Male; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology*
D001286:Atropine Derivatives; D001285:Atropine; D008238:Lysergic Acid Diethylamide; D012601:Scopolamine; D006152:Cyclic GMP; D006220:Haloperidol; D001058:Apomorphine